New Results

Pathways analyses of schizophrenia GWAS focusing on known and novel drug targets

H.A. Gaspar, G. Breen
doi: https://doi.org/10.1101/091264

Article Information

doi 
https://doi.org/10.1101/091264
History 
  • August 18, 2017.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. H.A. Gaspar1,2* and
  2. G. Breen1,2
  1. 1King’s College London, Institute of Psychiatry, Psychology and Neuroscience, MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, UK
  2. 2National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Trust, UK
Back to top
Posted August 18, 2017.
Download PDF

Supplementary Material

Email
Pathways analyses of schizophrenia GWAS focusing on known and novel drug targets
H.A. Gaspar, G. Breen
bioRxiv 091264; doi: https://doi.org/10.1101/091264
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area